Stock listing

6547 Stock Price, News, Filings & Events — Medigen Vaccine Biologics Corp.

Selected listing: 6547 · TPEX · TWD · TW

This page tracks Medigen Vaccine Biologics Corp.'s 6547:TPEX listing on TPEX in TWD for TW, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 6547:TPEX. 6547:TPEX is the stock-level entry point for investors researching Medigen Vaccine Biologics Corp., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Medigen Vaccine Biologics Corp. is a publicly traded company on the Taiwan stock market under the ticker 6547. The company has a market capitalization of approximately NT$485.92 million. Medigen focuses on the development and production of vaccines, contributing to public health initiatives.

6547:TPEXTWDTWUpdated August 15, 2026
Medigen Vaccine Biologics Corp. logo
Ticker
6547:TPEX
Asset type
Stock
Market cap
$534.2M
Sector
Health Technology
Industry
Biotechnology
Exchange
TPEX
Currency
TWD

Medigen Vaccine Biologics Corp. 6547:TPEX stock context

This page tracks Medigen Vaccine Biologics Corp.'s 6547:TPEX listing on TPEX in TWD for TW, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 6547:TPEX. 6547:TPEX is the stock-level entry point for investors researching Medigen Vaccine Biologics Corp., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Medigen Vaccine Biologics Corp. is a publicly traded company on the Taiwan stock market under the ticker 6547. The company has a market capitalization of approximately NT$485.92 million. Medigen focuses on the development and production of vaccines, contributing to public health initiatives.

Research Medigen Vaccine Biologics Corp.